APA (7th ed.) Citation

Y, T., H, J., X, T., F, M., J, W., P, Z., . . . W, Z. Non-Luminal Disease Score for Everolimus in Patients with Hormone Receptor‑positive and Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: A Multicenter and Retrospective Study. Dove Medical Press.

Chicago Style (17th ed.) Citation

Y, Tan, Jiang H, Tian X, Ma F, Wang J, Zhang P, Xu B, Fan Y, and Zhao W. Non-Luminal Disease Score for Everolimus in Patients With Hormone Receptor‑positive and Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: A Multicenter and Retrospective Study. Dove Medical Press.

MLA (9th ed.) Citation

Y, Tan, et al. Non-Luminal Disease Score for Everolimus in Patients With Hormone Receptor‑positive and Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: A Multicenter and Retrospective Study. Dove Medical Press.